Paula Hanford
Paula Hanford is the chief executive of UK-based Pancreatic Cancer Action, who described the discovery of daraxonrasib as one of the most significant developments in pancreatic cancer treatment, providing hope for patients with previously limited options.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Paula Hanford, the chief executive of UK-based Pancreatic Cancer Action, called the discovery one of the most significant developments in treatment.
9